Your healthcare provider will help you choose the best option based on factors like: Your medical history and current health status Your weight loss goals Your risk of potential side effects Your insurance coverage and ability to access the medication The availability of compounded versions, which may offer cost savings However, its always important to discuss the pros and cons of compounded medications with your healthcare provider
NHS availability, if it comes, would follow a NICE assessment after MHRA approval
For individuals who cannot tolerate weight loss injections after cholecystectomy, or for whom they are unsuitable, several evidence-based alternatives exist within NHS pathways
Even more impressive, 42% of tirzepatide users lost 15% or more of their body weight, compared to just 18% of semaglutide users
Without health coverage, semaglutide brand names can be pricey